The immunosurveillance of transformed cells by the immune system remains one of the most controversial and poorly understood areas of immunity. Gene-targeted mice have greatly aided our understanding of the key effector molecules in tumor immunity. Herein, we describe spontaneous tumor development in gene-targeted mice lacking interferon (IFN)-γ and/or perforin (pfp), or the immunoregulatory cytokines, interleukin (IL)-12, IL-18, and tumor necrosis factor (TNF). Both IFN-γ and pfp were critical for suppression of lymphomagenesis, however the level of protection afforded by IFN-γ was strain specific. Lymphomas arising in IFN-γ-deficient mice were very nonimmunogenic compared with those derived from pfp-deficient mice, suggesting a comparatively weaker immunoselection pressure by IFN-γ. Single loss of IL-12, IL-18, or TNF was not sufficient for spontaneous tumor development. A significant incidence of late onset adenocarcinoma observed in both IFN-γ– and pfp-deficient mice indicated that some epithelial tissues were also subject to immunosurveillance.
Skip Nav Destination
Article navigation
1 July 2002
Article Contents
Brief Definitive Report|
July 01 2002
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
Shayna E.A. Street,
Shayna E.A. Street
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Search for other works by this author on:
Joseph A. Trapani,
Joseph A. Trapani
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Search for other works by this author on:
Duncan MacGregor,
Duncan MacGregor
2Department of Anatomical Pathology, Austin and Repatriation Medical Centre, Heidelberg 3084, Australia
Search for other works by this author on:
Mark J. Smyth
Mark J. Smyth
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Search for other works by this author on:
Shayna E.A. Street
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Joseph A. Trapani
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Duncan MacGregor
2Department of Anatomical Pathology, Austin and Repatriation Medical Centre, Heidelberg 3084, Australia
Mark J. Smyth
1Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Institute, East Melbourne, Victoria 8006, Australia
Address correspondence to M.J. Smyth, Cancer Immunology, St. Andrews Place, East Melbourne, Victoria 3002, Australia. Phone: 61-3-9656-3728; Fax: 61-3-9656-1411; E-mail: [email protected]
The online version of this article contains supplemental material.
Received:
January 14 2002
Accepted:
April 22 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (1): 129–134.
Article history
Received:
January 14 2002
Accepted:
April 22 2002
Citation
Shayna E.A. Street, Joseph A. Trapani, Duncan MacGregor, Mark J. Smyth; Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ . J Exp Med 1 July 2002; 196 (1): 129–134. doi: https://doi.org/10.1084/jem.20020063
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement